Skip to main content

Milestone 9.H

Launch research programs to develop and validate sensitive neuropsychological and behavioral assessment measures to detect and track the earliest clinical manifestations of AD and AD-related dementias.

Success Criteria

Development of at least one sensitive neuropsychological assessment measure that has been validated for the detection or tracking of the earliest clinical manifestations of AD and AD-related dementias.

Extend ongoing research on social and emotional functioning and decision-making in MCI/AD to identy early behavioral markers of disease.

Support research to develop clinical tools for assessment of early deficits in decision-making, motivation and social and emotional functioning in AD.

Time Required

2014 to 2022

Research Implementation Area

Biomarkers

CADRO Category

B. Diagnosis, Assessment and Disease Monitoring